Retail news
FDA Says No to OTC Mevacor
Written by
G
Guest contributorThe Food and Drug Administration (FDA) has rejected Merck's application to take the cholesterol-lowering drug, Mevacor, over-the-counter.
Back to News
The RetailWire Daily
A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.
Want to know more? Learn more